NCT03367351

Brief Summary

The goal of this pilot study is to produce a high-quality, theory-driven, therapeutic, web-based intervention that provides extended training and peer support to adolescents and young adults with type 1 diabetes who are newly implementing CGM. Overall, this web-based intervention represents an efficient way to bring together professionally-supported CGM educational materials and social support to overcome known barriers and address factors associated with inconsistent CGM use.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 4, 2017

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 8, 2017

Completed
3 months until next milestone

Study Start

First participant enrolled

March 9, 2018

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2018

Completed
Last Updated

December 17, 2018

Status Verified

December 1, 2018

Enrollment Period

8 months

First QC Date

December 4, 2017

Last Update Submit

December 14, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Adherence to CGM

    Analyzing CGM data to determine if there is a difference in adherence between treatment and control group

    3 months

Secondary Outcomes (3)

  • HbA1c

    1-week run in, 3-months post implementation

  • CGM Satisfaction

    1-week run in, 7 weeks

  • CGM Self-Efficacy

    1-week run in, 7 weeks

Study Arms (2)

Web-Based Educational Intervention

EXPERIMENTAL

Participants receiving the Web-Based Educational Intervention will be enrolled to the research protocol for six weeks of module-based learning and online discussion sessions and followed for a total of 3-months post CGM implementation to collect study measures.

Behavioral: Web-Based EducationBehavioral: Social Support

Standard of Care

PLACEBO COMPARATOR

Participants will receive standard clinical care. Similar study measures will be collected to compare between groups.

Behavioral: Standard of Care

Interventions

Completion of a CGM specific web-based educational intervention that includes a series of online learning modules.

Web-Based Educational Intervention
Social SupportBEHAVIORAL

Engagement in peer-led CGM specific discussion boards

Web-Based Educational Intervention

Standard of Care - serves as the control group for the treatment arm

Standard of Care

Eligibility Criteria

Age15 Years - 24 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Ability to read and speak English
  • Diagnosed with type 1 diabetes (T1D) for \> 3 months before consent is obtained
  • Aged \>15 years and \<24 years at time of enrollment
  • Must have access to a smartphone, tablet or laptop/desktop computer with high speed internet access and speaker
  • Must be using/initiating a Dexcom CGM

You may not qualify if:

  • Cognitive or learning disability (e.g., inability to read) that would preclude their ability to comply with the study protocol
  • Significant medical comorbidity in the adolescent or young adult that could, in the opinion of the PI, affect subject's capacity to follow study protocol
  • Previous use of a CGM within the last 3 months
  • Unwilling or unlikely to return to clinic for a follow-up HbA1c test
  • Unwillingness to accept randomization

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Florida

Gainesville, Florida, 32603, United States

Location

Related Publications (1)

  • Smith MB, Albanese-O'Neill A, Yao Y, Wilkie DJ, Haller MJ, Keenan GM. Feasibility of the Web-Based Intervention Designed to Educate and Improve Adherence Through Learning to Use Continuous Glucose Monitor (IDEAL CGM) Training and Follow-Up Support Intervention: Randomized Controlled Pilot Study. JMIR Diabetes. 2021 Feb 9;6(1):e15410. doi: 10.2196/15410.

MeSH Terms

Conditions

Diabetes Mellitus, Type 1

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAutoimmune DiseasesImmune System Diseases

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • Madison B Smith, BSN, PhD Candidate

    University of Florida

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized, un-blinded intervention/control design
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 4, 2017

First Posted

December 8, 2017

Study Start

March 9, 2018

Primary Completion

November 1, 2018

Study Completion

November 1, 2018

Last Updated

December 17, 2018

Record last verified: 2018-12

Data Sharing

IPD Sharing
Will not share

Locations